Alyeska Investment Group
KNSA icon

Alyeska Investment Group’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Alyeska Investment Group’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-238,412
Closed -$2.81M – 627
2021
Q4 		$2.81M Sell
238,412
-25,000
-9% -$307K 0.03% 389
2021
Q3 		$3M Buy
263,412
+13,795
+6% +$180K 0.04% 420
2021
Q2 		$3.48M Buy
249,617
+25,000
+11% +$380K 0.04% 414
2021
Q1 		$4.16M Sell
224,617
-93,501
-29% -$1.91M 0.05% 363
2020
Q4 		$5.62M Sell
318,118
-13,421
-4% -$236K 0.08% 254
2020
Q3 		$5.08M Buy
331,539
+259,062
+357% +$4.86M 0.08% 263
2020
Q2 		$1.85M Buy
+72,477
New +$1.51M 0.03% 362
2020
Q1 		– Sell
-387,427
Closed -$4.29M – 427
2019
Q4 		$4.29M Buy
387,427
+24,806
+7% +$216K 0.06% 235
2019
Q3 		$3.09M Buy
362,621
+150,000
+71% +$1.66M 0.04% 264
2019
Q2 		$2.88M Buy
212,621
+81,119
+62% +$1.26M 0.04% 289
2019
Q1 		$2.38M Buy
+131,502
New +$2.54M 0.03% 271
2018
Q3 		– Sell
-84,313
Closed -$1.46M – 461
2018
Q2 		$1.46M Buy
+84,313
New +$1.53M 0.01% 372

Other funds holding KNSA

PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Alyeska Investment Group's KNSA Position: Q1 2022 in Review

Alyeska Investment Group sold out of Kiniksa Pharmaceuticals (KNSA) in Q1 2022, closing a stake of 238,412 shares — an estimated $2.81M sold.

Alyeska Investment Group first reported a position in KNSA in Q2 2018 and held it in 12 quarters. The position peaked at $5.62M in Q4 2020. 96 funds tracked by Wall St. Rank hold KNSA as of Q1 2022.

  • Alyeska Investment Group reported no remaining Kiniksa Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Alyeska Investment Group sold 238,412 Kiniksa Pharmaceuticals shares in Q1 2022, an estimated $2.81M.
  • Alyeska Investment Group first reported a position in Kiniksa Pharmaceuticals in Q2 2018 and held it in 12 quarters.
  • Alyeska Investment Group's Kiniksa Pharmaceuticals position peaked at $5.62M in Q4 2020.
  • 96 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2022.

Based on Alyeska Investment Group's 13F filing for Q1 2022, filed 16 May 2022.